Skip to main content
. Author manuscript; available in PMC: 2022 May 3.
Published in final edited form as: J Med Chem. 2020 Oct 6;63(20):11934–11944. doi: 10.1021/acs.jmedchem.0c01198

Table 3.

MICs in μg/mL (μM) of HSGN-218 and control antibiotics against vancomycin-resistant enterococci (VRE) and Escherichia coli isolates.

Compound/Control Antibiotic E. faecium ATCC 700221 E. faecalis ATCC 51299 E. coli JW55031 (TolC Mutant E. coli BW25113 (wild-type strain)
HSGN-218 0.125 (0.29) 0.06 (0.14) 4 (9.2) >16 (>36.8)
Vancomycin 32 (22.1) >64 (>44.2) >64 (>44.2) >64 (>44.2)
Metronidazole >64 (>373.9) >64 (>373.9) NT1 NT
Linezolid 1 (3.0) 1 (3.0) 16 (47.4) >64 (>189,7)
Gentamicin NT NT 0.25 (0.52) 0.25 (0.52)

NT1, not tested